BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 5, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 20, 2013
View Archived Issues
New anticancer agents prepared by Bayer
Read More
Wacker develops production process for Metheresis' anticancer candidate
Read More
New liposomal nanoparticle formulation tested for activity in ovarian cancer
Read More
ALT-801 evaluated in phase I/II trial in patients with urothelial cancer
Read More
Spanish researchers disclose new calpain inhibitors
Read More
Evestra discloses novel progesterone receptor antagonists
Read More
Eli Lilly discloses novel notch signaling inhibitors
Read More
FDA accepts umeclidinium bromide/vilanterol NDA
Read More
KBP BioSciences synthesizes new antibacterial agents
Read More
Intra-Cellular Therapies completes phase I trial of ITI-214
Read More
Isis Pharmaceuticals begins phase II/III study of ISIS-TTRRx
Read More
Peregrine Pharmaceuticals updates topline data from bavituximab trial
Read More
Reduction in tumor burden found with ALT-803 in rodent models
Read More
Sucampo launches Rescula in the U.S.
Read More
Nippon Kayaku files for additional approval of Hycamtin in Japan
Read More
Merck & Co. presents new inhibitors of mTORC1/2
Read More
Antiproliferative activity demonstrated for palbociclib in RCC cells
Read More
German scientists synthesize novel glycine transporter inhibitors
Read More
Stem Cell Therapeutics enters joint-venture agreement
Read More
Encouraging immunogenicity results reported from phase III program for NX-1207
Read More
C3 Jian completes enrollment for phase I study of candidate for cavity prevention
Read More
Phase III data further support efficacy of sofosbuvir
Read More
Two novel antibodies enhance response to chemotherapy in NSCLC
Read More
Galectin Therapeutics to collaborate with the University of Georgia on drug discovery
Read More
Ono files additional indication application for Onoact 50 for injection in Japan
Read More
AcelRx Pharmaceuticals provides update on trials of sufentanil NanoTab system
Read More